Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease Review uri icon

Overview

MeSH Major

  • Lupus Erythematosus, Systemic

abstract

  • Cytotoxic agents are superior to glucocorticoid therapy for the treatment of proliferative lupus nephritis, but the optimal duration and intensity of cytotoxic therapy remain undefined. Definitive studies of the treatment of autoimmune thrombocytopenia and acute pulmonary disease and of the diagnosis and treatment of neuropsychiatric disease are not available.

publication date

  • January 1995

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 7755231

Additional Document Info

start page

  • 940

end page

  • 50

volume

  • 122

number

  • 12